Long-term outcome of renal nerve denervation (RDN) for resistant hypertension

Author:

Panchavinnin Pariya,Wanthong Sirisawat,Roubsanthisuk Weranuj,Tresukosol Damras,Buranakitjaroen Peera,Chotruangnapa Chavalit,Watanapa Wattana,Pongakasira Rungtiwa,Wongpraparut NattawutORCID

Abstract

AbstractWe aimed to determine the long-term outcome of renal denervation (RDN). All patients with resistant hypertension who underwent RDN between 2012 and 2018 at Siriraj Hospital were included in the study. Patients were followed up at 3, 6, and 12 months and then annually up to 9 years. Effectiveness of the RDN outcome was defined by either (1) a reduction in office systolic BP ≥ 10 mmHg, (2) a reduction in the number of antihypertensive drugs taken, or (3) both outcomes being achieved. In total, 18 RDN procedures were performed during the study period. The mean and longest follow-up periods were 52 months and 104 months, respectively. Heterogeneous BP responses after RDN for resistant hypertension were observed. Effectiveness of the RDN outcome was achieved in 88% of the patients at 1 year and in >80% of the patients during the entire follow-up at each time point up to 9 years.

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference17 articles.

1. Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of hypertension global hypertension practice guidelines. Hypertension.2020;75:1334–57.

2. Wongpraparut N, Tresukosol D, Roubsantisuk W, Buranakitjaroen P, Chotivoraniyakul C, Pongakasira R. Effect of renal nerve denervation for resistant hypertension in Thai patients: a report of the first cases series in Thailand. J Med Assoc Thai. 2014;97:S155–61.

3. Wang TD, Lee YH, Chang SS, Tung YC, Yeh CF, Lin YH, et al. 2019 consensus statement of the Taiwan Hypertension Society and the Taiwan Society of Cardiology on renal denervation for the Management of Arterial Hypertension. Acta Cardiol Sin. 2019;35:199–230.

4. Kario K, Kim BK, Aoki J, Wong AY, Lee YH, Wongpraparut N, et al. Renal Denervation in Asia: Consensus Statement of the Asia Renal Denervation Consortium. Hypertension.2020;75:590–602.

5. Bhatt DL, Kandzari DE, O’Neill WW, D’Agostino R, Flack JM, Katzen BT, et al. A controlled trial of renal denervation for resistant hypertension. N. Engl J Med. 2014;370:1393–401.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3